OppenheimJJZachariaeCOMukaidaNMatsushimaK. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol1991;9:617–48.
2.
DeMariaTFMurwinDM. Tumor necrosis factor in endotoxin-induced otitis media in the chinchilla. In: MogiGHonjoIIshiiTTakasakaT, eds. Recent Advances in Otitis Media. Proceedings of the Second Extraordinary International Symposium on Recent Advances in Otitis Media. Amsterdam, the Netherlands: Kugler Publications, 1994:633–5.
3.
NellMJGroteJJ. Endotoxin and tumor necrosis factor–alpha in middle ear effusions in relation to upper airway infection. Laryngoscope1999;109:1815–9.
4.
LinJHarutaAKawanoH. Induction of mucin gene expression in middle ear of rats by tumor necrosis factor–alpha: Potential cause for mucoid otitis media. J Infect Dis2000;182:882–7.
5.
KawanoHHarutaATsuboiY. Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: The pathological basis for mucin hyperproduction in mucoid otitis media. Ann Otol Rhinol Laryngol2002;111:415–22.
6.
LeeDHParkYSJungTTYeoSWChoiYCJeonE. Effect of tumor necrosis factor–alpha on experimental otitis media with effusion. Laryngoscope2001;111:728–33.
7.
JeonEJParkYSChoiYCYeoSWJungTT. Effect of inhibitor of tumor necrosis factor–alpha on experimental otitis media with effusion. Ann Otol Rhinol Laryngol2001;110:917–21.
8.
BarzilaiALeibovitzELaverJH. Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics. Infection1999;27:173–6.
9.
WatanabeTHiranoTSuzukiMKuronoYMogiG. Role of interleukin-1 beta in a murine model of otitis media with effusion. Ann Otol Rhinol Laryngol2001;110:574–80.
10.
YetiserSSatarBGumusgunAUnalFOzkaptanY. Tumor necrosis factor–alpha and interleukin-1 beta levels in recurrent and persistent otitis media with effusion. Otolaryngol Head Neck Surg2002;126:417–22.
11.
Narkio-MakelaMTeppoAMMeriS. Complement C3 cleavage and cytokines interleukin-1 beta and tumor necrosis factor–alpha in otitis media with effusion. Laryngoscope2000;110:1745–9.
12.
KuzielWAGreeneWC. Interleukin-2. In: ThompsonA, ed. The cytokine handbook. New York, NY: Academic Press, 1991:83–102.
13.
MelhusÅRyanAF. Expression of cytokine genes during pneumococcal and nontypeable Hemophilus influenzae acute otitis media in the rat. Infect Immun2000;68:4024–31.
14.
KitaHHimiT. Cytokine and chemokine induction using cell wall component and toxin derived from gram-positive bacteria in the rat middle ear. Acta Otolaryngol (Stockh)1999;119:446–52.
15.
StarenEDEssnerREconomouJS. Overview of biological response modifiers. Semin Surg Oncol1989;5:379–84.
16.
StroberWJamesSP. The interleukins. Pediatr Res1988;24:549–57.
17.
SonodaEHitoshiYYamaguchiN. Differential regulation of IgA production by TGF-beta and IL-5: TGF-beta induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgA-secreting cells. Cell Immunol1992;140:158–72.
18.
SobolSETahaRSchlossMD. T(H)2 cytokine expression in atopic children with otitis media with effusion. J Allergy Clin Immunol2002;110:125–30.
19.
HeikkinenTGhaffarFOkoroduduAOChonmaitreeT. Serum interleukin-6 in bacterial and nonbacterial acute otitis media. Pediatrics1998;102:296–9.
20.
HiranoT. Interleukin-6. In: ThompsonA, ed. The cytokine handbook. 2nd ed. New York, NY: Academic Press, 1994:145–70.
21.
SatoKLiebelerCLQuarteyMKLeCTGiebinkGS. Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model. Infect Immun1999;67:1943–6.
22.
BarzilaiaADekelBDaganRLeibovitzE. Middle ear effusion IL-6 concentration in bacterial and non-bacterial acute otitis media. Acta Paediatr2000;89:1068–71.
23.
SchroderJM. The neutrophil-activating peptidel/interleukin 8, a novel neutrophil chemotactic cytokine. Arch Immunol Ther Exp (Warsz)1992;40:23–31.
24.
PospiechLJaworskaMKubackaM. Soluble L-selectin and interleukin-8 in otitis media with effusion. Auris Nasus Larynx2000;27:213–7.
25.
LeibovitzEDaganRLaverJH. Interleukin 8 in middle ear fluid during acute otitis media: Correlation with aetiology and bacterial eradication. Arch Dis Child2000;82:165–8.
26.
SchousboeLPRasmussenLMOvesenT. RANTES in otitis media with effusion: Presence, role and correlation with cytokines and microbiology. APMIS2001;109:441–6.
27.
JangCHKimYH. Demonstration of RANTES and eosinophilic cataionic protein in otitis media with effusion with allergy. Int J Pediatr Otorhinolaryngol2003;67:531–3.
28.
SmirnovaMGBirchallJPPearsonJP. In vitro study of IL-8 and goblet cells: Possible role of IL-8 in the aetiology of otitis media with effusion. Acta Otolaryngol (Stockh)2002;122:146–52.
29.
SkotnickaBHassmannE. Cytokines in children with otitis media with effusion. Eur Arch Otorhinolaryngol2000;257:323–6.
30.
DongWLiZZhouS. Superoxide dismutase and cytokines in otitis media with effusion [in Chinese]. Lin Chuang Er Bi Yan Hou Ke Za Zhi2001;15:452–4.
31.
HebdaPAPiltcherOBSwartsJDAlperCMZeeviADoyleWJ. Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection. Laryngoscope2002;112:1657–62.
32.
JangCHKimYH. Characterization of cytokines present in pediatric otitis media with effusion: Comparison of allergy positive and negative. Int J Pediatr Otorhinolaryngol2002;66:37–40.
33.
DownsBWButehornHFIIIPrazmaJRoseASStamatJCPillsburyHCIII. Action of histamine on eustachian tube function. Otolaryngol Head Neck Surg2001;124:414–20.
34.
EbertCSJr.PollockHWDubinMG. Effect of intranasal histamine challenge on eustachian tube function. Int J Pediatr Otorhinolaryngol2002;63:189–98.
35.
JungHJKimMWLeeJH. Expression of vascular endothelial growth factor in otitis media. Acta Otolaryngol (Stockh)1999;119:801–8.
36.
RheeCKJeongPSKimYHChungPSJungTTK. Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. Ann Otol Rhinol Laryngol1999;108:453–8.
37.
TjoelkerLWStafforiniDM. Platelet-activating factor acetylhydrolases in health and disease. Biochim Biophys Acta2000;1488:102–23.
38.
LinJVambutasAHarutaAPaparellaMMGiebinkGSKimY. Pneumococcus activation of the 5-lipoxygenase pathway and production of glycoproteins in the middle ear of rats. J Infect Dis1999;179:1145–51.
39.
TadaNFurukawaMOguraM. Experimental otitis media with effusion induced by leukotriene D4. Auris Nasus Larynx2002;29:127–32.
40.
MoncadaS. The biology of nitric oxide. Funct Neurol1997;12:134–40.
41.
TakoudesTGHaddadJJr.. Evidence of oxygen free radical damage in human otitis media. Otolaryngol Head Neck Surg1999;120:638–42.
42.
JohnEORussellPTNamBHJinnTHJungTT. Concentration of nitric oxide metabolites in middle ear effusion. Int J Pediatr Otorhinolaryngol2001;60:55–8.
43.
JohnEOO-LeeTJParkSKMoorheadMTJungTTK. Correlation between nitric oxide metabolites and mucin. In: LimDJBluestoneCDCasselbrantML, eds. Abstracts of the Eighth International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 2003:71.
44.
O-LeeTJParkSKJohnEOMoorheadMTJungTTK. Effect of nitric oxide on mucin production in experimental otitis media. In: LimDJBluestoneCDCasselbrantML, eds. Abstracts of the Eighth International Symposium on Recent Advances in Otitis Media, Ft Lauderdale, Fla, 2003:72.
45.
MorineauOLecainEPortierFTedguyATran Ba HuyPHermanP. Production of nitric oxide by the middle ear epithelium and subsequent inhibition of sodium transport. Acta Otolaryngol (Stockh)2001;121:371–7.
46.
OndreyFGJuhnSKAdamsGL. Early-response cytokine expression in adult middle ear effusions. Otolaryngol Head Neck Surg1998;119:342–5.
47.
AlbinoAPKimmelmanCPParisierSC. Cholesteatoma: A molecular and cellular puzzle. Am J Otol1998;19:7–19.
48.
OttavianiFNegliaCBBertiE. Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?. Acta Otolaryngol (Stockh)1999;119:462–7.
49.
AlbinoAPReedJABogdanyJASassoonJParisierSC. Increased numbers of mast cells in human middle ear cholesteatomas: Implications for treatment. Am J Otol1998;19:266–72.
50.
AkimotoRPawankarRYagiTBabaS. Acquired and congenital cholesteatoma: Determination of tumor necrosis factor–alpha, intercellular adhesion molecule-1, interleukin-1-alpha, and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec2000;62:257–65.
51.
ChungJWYoonTH. Different production of interleukin-1 alpha, interleukin-1 beta and interleukin-8 from cholesteatomatous and normal epithelium. Acta Otolaryngol (Stockh)1998;118:386–91.
52.
SchonermarkMMesterBKempfHGBlaserJTschescheHLenarzT. Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol (Stockh)1996;116:451–6.
53.
SchonermarkMPIssingPRErbrichBKLenarzT. Expression pattern of the plasminogen activator-plasmin system in human cholesteatoma. Ann Otol Rhinol Laryngol1999;108:245–52.
